Century Therapeutics (IPSC) Capital Expenditures (2020 - 2026)
Century Therapeutics (IPSC) reported Capital Expenditures of $584000.0 for Q1 2026, up 22.95% year-over-year from $475000.0 in Q1 2025, and up 520.14% quarter-over-quarter from -$139000.0 in Q4 2025.
Century Therapeutics (IPSC) Capital Expenditures (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 7 years of Capital Expenditures data on file, last reported at $584000.0 in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $584000.0, up 22.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $957000.0 (down 57.64% YoY), and the FY2025 annual result was $848000.0, up 450.65% from the prior year.
- Capital Expenditures advanced to $584000.0 in Q1 2026 per IPSC's latest filing, from -$139000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $24.0 million in Q3 2022 and troughed at -$21.7 million in Q4 2022.
- A 5-year average of $1.2 million and a median of $539000.0 in 2024 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures sank 229.67% in 2022, then jumped 229.2% in 2023.
- A 5-year view of Capital Expenditures shows it stood at -$21.7 million in 2022, then jumped by 104.52% to $980000.0 in 2023, then tumbled by 72.96% to $265000.0 in 2024, then tumbled by 152.45% to -$139000.0 in 2025, then soared by 520.14% to $584000.0 in 2026.
- Business Quant data shows IPSC's Capital Expenditures at $584000.0 in Q1 2026, -$139000.0 in Q4 2025, and $195000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Century Therapeutics | 444.99 Mn | 444.99 Mn | - | 584,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 584,000.00 |
| Mar 31, 2026 | 584,000.00 |
| Dec 31, 2025 | -139,000.00 |
| Dec 31, 2025 | -139,000.00 |
| Sep 30, 2025 | 195,000.00 |
| Sep 30, 2025 | 195,000.00 |
| Jun 30, 2025 | 317,000.00 |
| Jun 30, 2025 | 317,000.00 |
| Mar 31, 2025 | 475,000.00 |
| Mar 31, 2025 | 475,000.00 |
| Jun 30, 2024 | 265,000.00 |
| Jun 30, 2024 | 265,000.00 |
| Mar 31, 2024 | 539,000.00 |
| Mar 31, 2024 | 539,000.00 |
| Dec 31, 2023 | 980,000.00 |
| Dec 31, 2023 | 980,000.00 |
| Sep 30, 2023 | 3.27 Mn |
| Sep 30, 2023 | 3.27 Mn |
| Jun 30, 2023 | 4.50 Mn |
| Jun 30, 2023 | 4.50 Mn |